Improvements of doxorubicin-induced antitumor activity and adverse reaction by combined citrulline.

Biological & pharmaceutical bulletin2014Miyashita M, Sadzuka Y

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsAntineoplastic AgentsAntioxidantsCell Line, TumorCitrullineDoxorubicinDrug SynergismDrug Therapy, CombinationEquilibrative Nucleoside Transporter 1HeartLipid PeroxidationMaleMiceMice, Inbred StrainsNeoplasms

DOI 10.1248/bpb.b13-00811

PMID 24583863

View source →